PET-CT with Gallium 68(PSMA) Doctors Abroad — Page 3

Dr. Cevper Ersoz is a urologist at Medipol Acibadem District Hospital in Istanbul. He specializes in robotic and laparoscopic surgery for urological cancers. Dr. Ersoz is a Fellow of the European Board of Urology (FEBU). He completed an observership in urologic surgery at the University of Michigan, USA.

• Author of over 130 national and international peer-reviewed scientific publications.
• Treats benign prostate hyperplasia using HoLEP, TuLEP, and Rezum techniques.
• Performs minimally invasive procedures for stone diseases, including PCNL and URS.
• Practices at JCI-accredited Medipol Acibadem, which uses the da Vinci robotic system.

Dr. Cemil Bilir is a professor of medical oncology at VM Medical Park Pendik Hospital in Istanbul. He specializes in immunotherapy and chemotherapy for lung, breast, and prostate cancers. A former research fellow at Northeastern University in Boston, he focused on pharmaceutical biotechnology and nanomedicine. Dr. Bilir works at a JCI-accredited facility where academic physicians provide around-the-clock care.

• Member of the American Society of Clinical Oncology (ASCO) and ESMO.
• Completed a specialized clinical rotation at the Cleveland Clinic in the U.S.
• Treats complex oncological cases, including stage 4 lung cancer and sarcoma.
• Current Ph.D. student in inorganic chemistry at Sakarya University.

Dr. Navarro Vilches leads the Urology Unit at Quirónsalud Marbella Hospital. He specializes in male reproductive health and lower urinary tract surgery. Dr. Vilches completed a study stay at the Memorial Sloan-Kettering Cancer Center in New York. He is a co-founder of the Urologic Surgery Institute of Malaga.

• Expert in renal surgery and robotic da Vinci prostatectomy.
• Former member of the Renal Transplant Unit at Carlos Haya Hospital.
• Treats conditions including BPH, varicocele, and Peyronie's disease.
• Works at JCI-accredited Quirónsalud Marbella, part of Spain's largest private hospital group.

Dr. Ramazan Gökhan Atış is a professor of urological surgery at Medipol Acıbadem District Hospital in Istanbul. He is the Secretary General of the Endourology Society. Dr. Atış trained in robotic urology at the Heidelberg University Heilbronn Clinic. He specializes in genitourinary reconstruction and urological oncology.

• Published over 100 articles in international and peer-reviewed medical journals.
• Performs robotic da Vinci prostatectomy and Holmium Laser Enucleation of the Prostate (HoLEP).
• Treats complex conditions including pediatric urolithiasis, urethral strictures, and Peyronie's disease.
• Practices at JCI-accredited Medipol Acıbadem, which utilizes the da Vinci robotic system.

Dr. Mustafa Serkan Alemdar is a clinical oncologist at Medical Park Antalya Hospital Complex. He specializes in treating complex solid tumors and blood cancers. Dr. Alemdar completed his medical degree and oncology fellowship at Akdeniz University. He is an active member of the Turkish Society of Medical Oncology.

• Treats a wide range of cancers including breast, lung, and prostate.
• Expert in hematology-oncology for conditions like leukemia, myeloma, and lymphoma.
• Performs systemic therapies such as chemotherapy, immunotherapy, and targeted biological therapy.
• Works at a facility that houses specialized oncology-bone marrow units and LINAC technology.

EDUCATION:

2000 - SSK Okmeydanı Training and Research Hospital, .

1996 - Istanbul University, Istanbul Faculty of Medicine

EXPERIENCE:

2019 - Istanbul Medipol University Pendik Hospital

2017 - 2019 - Private Adatıp Kurtköy Hospital

2005 - 2017 - Private Avicenna Umut Hospital

2003 - 2005 - SSK Yalova Regional Hospital

2002 - 2003 - Kayseri Military Hospital

Dr. Ugur Aferin is a urological surgeon at Istanbul Florence Nightingale Hospital. He specializes in robotic and minimally invasive urological surgery. Dr. Aferin is a published researcher on mitochondrial DNA as a prostate cancer biomarker. He performs complex procedures including robotic prostatectomy and nephrectomy.

• Uses the Da Vinci robotic system for prostate and kidney surgeries.
• Treats conditions ranging from erectile dysfunction to localized prostate cancer.
• Co-authored research on urodynamic curve patterns in the journal Urology.
• Works at a JCI-accredited facility, Turkey's first Smart-and-Green hospital.

Dr. Ercan Ozden is a medical oncologist and internal medicine specialist at VM Medical Park Pendik. He provides treatment for a wide range of cancers, including breast, lung, and colon cancer. Dr. Ozden trained at Istanbul University, Cerrahpasa Faculty of Medicine. He later completed a medical oncology subspecialty at Kocaeli University.

• Specializes in immunotherapy, target therapy, and chemotherapy for complex cases.
• Treats patients at a JCI-accredited hospital in Istanbul.
• Performs staging and biopsies for liver, lung, and pancreatic tumors.
• Provides targeted immunotherapy using medications like Keytruda.

Dr. Ayse Irem Yasin is an associate professor and board-certified oncologist at Medipol Acibadem District Hospital. She uses PET-CT with Gallium 68(PSMA) to detect and track urological and gastrointestinal cancers.

• Earned an ESMO Board Certification in Paris – a benchmark for excellence in oncology
• Completed observerships at Cleveland Clinic and Harvard Medical School in the USA
• Specialized training at University of Piemonte Orientale breast cancer unit in Italy
• Fellowship-trained in medical oncology at Bezmialem Vakif University in Istanbul
• Expertise includes diagnosing brain tumors, soft tissue sarcomas, and lung cancer

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Gul Alco is a radiation oncologist and Professor at Medipol Acibadem District Hospital in Istanbul. She excels in treating complex cases, including stage 4 lung and liver cancers. Dr. Alco utilizes the CyberKnife and Da Vinci robotic systems for precise tumor targeting. She works at a JCI-accredited facility known for its high safety standards.

• Specializes in brachytherapy and high-intensity focused ultrasound ablation (HIFU).
• Performs radiofrequency ablation and proton-beam therapy for various malignancies.
• Treats pancreatic, breast, ovarian, and brain cancers using targeted radiation.
• Expert in nuclear medicine diagnostics, including PET-CT with Gallium 68.

Dr. Zohar Dotan heads the urology department at Sheba Medical Center. He specializes in treating prostate and kidney cancers using PET-CT with Gallium 68(PSMA) for precise staging.

• Fellowship-trained in uro-oncology at Memorial Sloan Kettering Cancer Center in New York
• President of the Israeli Uro-Oncology Society
• Recipient of prestigious awards from the American Association of Clinical Surgery
• Author of 50+ scientific publications on urological cancer research
• Member of the American and European Associations of Urology

Prof. Gil Raviv, MD, PhD, is Director of the Andrology Unit at Sheba Medical Center. He was listed among the Best Doctors in Israel by Forbes in 2024. He is a leading expert in male fertility, sexual medicine, and reconstructive urology.

His primary focus is male infertility and fertility preservation. He performs advanced semen analysis according to WHO standards. He carries out testicular sperm retrieval (TESE, TESA, MESA) and semen cryopreservation. He also provides comprehensive fertility diagnostics with histological analysis.

He is a Professor at Tel Aviv University. He trained in Siena, Rome, and Tel Aviv. He completed a fellowship in infertility and impotence at Erasme Hospital. He received advanced training in reconstructive urethral surgery in Ghent. He is a member of the European Association of Urology, the International Society for Sexual Medicine, and the Israeli Urological Association.

Dr. Dorit Zilberman, MD, is a Senior Urologist at Sheba Medical Center. She is a pioneer of robotic and minimally invasive urologic surgery in Israel with over 20 years of experience. Her work focuses on urologic oncology, robotic and laparoscopic surgery, and endourology. She helped launch the da Vinci robotic surgery program at Sheba. Her expertise includes kidney, bladder, and prostate cancers, as well as laser lithotripsy for stones.

She completed advanced training in robotic laparoscopic surgery and endourology at Duke University Medical Center. She is a Senior Clinical Lecturer at Tel Aviv University. She has authored more than 160 scientific publications. She has received awards from the Israeli and American Urological Associations. She was listed in Forbes Israel Best Doctors in 2024. She is a member of the Israeli, American, and European Urological Associations and the Endourological Society.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Cem Basatac is an associate professor and urologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in laparoscopic and robotic urological surgery. Dr. Basatac provides treatment for complex conditions like kidney cysts, varicocele, and prostate disease. He works at a JCI-accredited facility that treats 200,000 patients annually.

• Performs robotic da Vinci prostatectomies and nephrectomies for kidney conditions.
• Uses HoLEP and GreenLight laser techniques for prostatic hyperplasia treatment.
• Specializes in microsurgical and embolization procedures for varicocele.
• Treats infertility related conditions including azoospermia and testicular tumors.

Dr. Mehmet Fatih Akbulut is a urologist at Medipol Bahçelievler University Hospital in Istanbul. He specializes in pediatric urology and robotic surgical techniques. Dr. Akbulut completed a specialized urology observer program at the University of Michigan Medical School. He focuses on kidney stone removal and prostate health.

• Performs robotic Da Vinci surgery for prostatectomy and nephrectomy.
• Expert in miniaturized percutaneous nephrolithotomy for treating large kidney stones.
• Authored over 30 international peer-reviewed publications on urological surgical outcomes.
• Treats complex conditions like Peyronie's disease, varicocele, and pediatric urological disorders.